Potential benefit of resection for stage IV gastric cancer: a national survey.
BACKGROUND
Controversy exists as to whether patients with stage IV gastric cancer should undergo surgical resection. We examined the association of gastrectomy with survival in this population.


METHODS
Stage IV gastric cancer diagnoses were identified using the SEER database (1988-2005). Analyses examined three subgroups divided on the basis of whether cancer-directed surgery was recommended and performed. Univariate analyses included chi-square and Kaplan-Meier survival analyses. Cox proportional hazards modeling was performed to assess independent determinants of survival.


RESULTS
Of 66,751 identified gastric cancer patients, 23,830 had stage IV disease. Resected patients had a significant survival advantage; survival outcomes of patients who had been recommended for, but had not undergone, surgery were identical to that of patients who had not been recommended (3 months vs. 9 months for resected, p < 0.0001). Furthermore, resection status was the most significant independent predictor of increased risk of death (hazard ratios 2.0 for non-cancer-directed surgery groups).


CONCLUSIONS
Patients with stage IV gastric cancer who undergo resection, a highly selected population, have significantly greater survival than unresected patients, including those who were recommended for, but did not receive, resection. Stage IV gastric cancer patients who are reasonable operative candidates should be offered resection.
Smith
Jillian K
JK
Surgical Outcomes Analysis and Research, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue North, S3-752, Worcester, MA 01655-0002, USA.
Hill
Joshua S
JS
Ng
Sing Chau
SC
McDade
Theodore P
TP
Shah
Shimul A
SA
Tseng
Jennifer F
JF
D000368:Aged; D005260:Female; D005743:Gastrectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D018426:SEER Program; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
J Cancer Res Clin Oncol. 2008 Feb;134(2):187-92
17611776
Ann Surg Oncol. 2008 Feb;15(2):415-23
17987343
Eur J Surg Oncol. 2010 Feb;36(2):148-54
19836921
Cancer. 1997 Dec 15;80(12):2333-41
9404711
Cancer. 2000 Feb 15;88(4):921-32
10679663
Surg Gynecol Obstet. 1987 Feb;164(2):151-4
2433778
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Hepatogastroenterology. 2001 Sep-Oct;48(41):1219-21
11677934
Cancer. 2009 Feb 15;115(4):741-51
19130464
Hepatogastroenterology. 1996 Jan-Feb;43(7):178-86
8682459
J Surg Oncol. 2007 Feb 1;95(2):118-22
17262741
Br J Surg. 2002 Nov;89(11):1438-43
12390389
World J Surg. 2000 Apr;24(4):465-72
10706921
World J Surg. 2006 Jan;30(1):21-7
16369718